Traveller vaccination rubella: Difference between revisions
(Created page with "__NOTOC__ {{Traveller vaccination human papillomavirus}} {{CMG}};{{AE}}{{MehdiP}} ==Overview== ==Disease cause== ==Transmission== ==Nature of the disease== ==Geographical...") |
Usama Talib (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}};{{AE}}{{MehdiP}} | {{CMG}};{{AE}}{{MehdiP}} | ||
==Overview== | ==Overview== | ||
Protection against rubella is not specific to the needs of travellers. In most countries rubella vaccine is routinely administered in childhood. Missing rubella vaccinations in travellers should be offered according to national recommendations. | |||
==Disease cause== | ==Disease cause== | ||
Rubella virus. | |||
==Transmission== | ==Transmission== | ||
Primarily by airborne respiratory droplets. | |||
==Nature of the disease== | ==Nature of the disease== | ||
Rubella is usually a mild childhood disease characterized by moderate fever, lymphadenopathy and a rash. In adults, transient arthralgia and arthritis may occur. Rubella infection in early pregnancy often results in miscarriage, stillbirth or multiple fetal defects (congenital rubella syndrome). | |||
==Geographical distribution== | ==Geographical distribution== | ||
Worldwide, but incidence depends on coverage of rubella vaccination. | |||
==Risk for travellers== | ==Risk for travellers== | ||
Non-immune travellers may be at risk when visiting countries with insufficient vaccination coverage. Particular attention should be paid to ensuring protection of women in early pregnancy or who may become pregnant during the period of travel. | |||
==Vaccine== | ==Vaccine== | ||
Live attenuated vaccine: available either in monovalent form (rubella component only) or in fixed combinations with one or more of vaccines against mumps, measles and varicella. Two intramuscular doses are administered at an interval of at least four weeks | |||
==Summary of vaccine data== | ==Summary of vaccine data== | ||
Revision as of 16:39, 20 April 2017
Template:Traveller vaccination human papillomavirus Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
Protection against rubella is not specific to the needs of travellers. In most countries rubella vaccine is routinely administered in childhood. Missing rubella vaccinations in travellers should be offered according to national recommendations.
Disease cause
Rubella virus.
Transmission
Primarily by airborne respiratory droplets.
Nature of the disease
Rubella is usually a mild childhood disease characterized by moderate fever, lymphadenopathy and a rash. In adults, transient arthralgia and arthritis may occur. Rubella infection in early pregnancy often results in miscarriage, stillbirth or multiple fetal defects (congenital rubella syndrome).
Geographical distribution
Worldwide, but incidence depends on coverage of rubella vaccination.
Risk for travellers
Non-immune travellers may be at risk when visiting countries with insufficient vaccination coverage. Particular attention should be paid to ensuring protection of women in early pregnancy or who may become pregnant during the period of travel.
Vaccine
Live attenuated vaccine: available either in monovalent form (rubella component only) or in fixed combinations with one or more of vaccines against mumps, measles and varicella. Two intramuscular doses are administered at an interval of at least four weeks